Immunologic aspects and rejection in solid organ versus reconstructive transplantation

T. Hautz, Gerald Brandacher, B. Zelger, V. S. Gorantla, W P Andrew Lee, J. Pratschke, S. Schneeberger

Research output: Contribution to journalArticle

Abstract

The immunosuppressive medications developed over the past 3 decades have paved the way for solid organ transplantation to become the treatment of choice for end-stage organ failure. At the end of the century, composite tissue transplantation in humans was performed with success using the same immunosuppressive medications and therapeutic principles. A decade later, experience from >100 cases of reconstructive transplantation have increased the knowledge, changed the view, and affected the therapeutic principles in this novel field. We herein portray the evolution of this novel type of transplant with particular reference to immunologic aspects, particularly differences between reconstructive and solid organ transplantation.

Original languageEnglish (US)
Pages (from-to)3347-3353
Number of pages7
JournalTransplantation Proceedings
Volume42
Issue number9
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Transplantation
Organ Transplantation
Immunosuppressive Agents
Tissue Transplantation
Therapeutics
Transplants

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Immunologic aspects and rejection in solid organ versus reconstructive transplantation. / Hautz, T.; Brandacher, Gerald; Zelger, B.; Gorantla, V. S.; Lee, W P Andrew; Pratschke, J.; Schneeberger, S.

In: Transplantation Proceedings, Vol. 42, No. 9, 11.2010, p. 3347-3353.

Research output: Contribution to journalArticle

Hautz, T, Brandacher, G, Zelger, B, Gorantla, VS, Lee, WPA, Pratschke, J & Schneeberger, S 2010, 'Immunologic aspects and rejection in solid organ versus reconstructive transplantation', Transplantation Proceedings, vol. 42, no. 9, pp. 3347-3353. https://doi.org/10.1016/j.transproceed.2010.09.020
Hautz, T. ; Brandacher, Gerald ; Zelger, B. ; Gorantla, V. S. ; Lee, W P Andrew ; Pratschke, J. ; Schneeberger, S. / Immunologic aspects and rejection in solid organ versus reconstructive transplantation. In: Transplantation Proceedings. 2010 ; Vol. 42, No. 9. pp. 3347-3353.
@article{2790e03dc093481ea96734e09e7a95f2,
title = "Immunologic aspects and rejection in solid organ versus reconstructive transplantation",
abstract = "The immunosuppressive medications developed over the past 3 decades have paved the way for solid organ transplantation to become the treatment of choice for end-stage organ failure. At the end of the century, composite tissue transplantation in humans was performed with success using the same immunosuppressive medications and therapeutic principles. A decade later, experience from >100 cases of reconstructive transplantation have increased the knowledge, changed the view, and affected the therapeutic principles in this novel field. We herein portray the evolution of this novel type of transplant with particular reference to immunologic aspects, particularly differences between reconstructive and solid organ transplantation.",
author = "T. Hautz and Gerald Brandacher and B. Zelger and Gorantla, {V. S.} and Lee, {W P Andrew} and J. Pratschke and S. Schneeberger",
year = "2010",
month = "11",
doi = "10.1016/j.transproceed.2010.09.020",
language = "English (US)",
volume = "42",
pages = "3347--3353",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Immunologic aspects and rejection in solid organ versus reconstructive transplantation

AU - Hautz, T.

AU - Brandacher, Gerald

AU - Zelger, B.

AU - Gorantla, V. S.

AU - Lee, W P Andrew

AU - Pratschke, J.

AU - Schneeberger, S.

PY - 2010/11

Y1 - 2010/11

N2 - The immunosuppressive medications developed over the past 3 decades have paved the way for solid organ transplantation to become the treatment of choice for end-stage organ failure. At the end of the century, composite tissue transplantation in humans was performed with success using the same immunosuppressive medications and therapeutic principles. A decade later, experience from >100 cases of reconstructive transplantation have increased the knowledge, changed the view, and affected the therapeutic principles in this novel field. We herein portray the evolution of this novel type of transplant with particular reference to immunologic aspects, particularly differences between reconstructive and solid organ transplantation.

AB - The immunosuppressive medications developed over the past 3 decades have paved the way for solid organ transplantation to become the treatment of choice for end-stage organ failure. At the end of the century, composite tissue transplantation in humans was performed with success using the same immunosuppressive medications and therapeutic principles. A decade later, experience from >100 cases of reconstructive transplantation have increased the knowledge, changed the view, and affected the therapeutic principles in this novel field. We herein portray the evolution of this novel type of transplant with particular reference to immunologic aspects, particularly differences between reconstructive and solid organ transplantation.

UR - http://www.scopus.com/inward/record.url?scp=78649478551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649478551&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2010.09.020

DO - 10.1016/j.transproceed.2010.09.020

M3 - Article

C2 - 21094778

AN - SCOPUS:78649478551

VL - 42

SP - 3347

EP - 3353

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 9

ER -